Loxapine Capsules USP recall: Labeling Error
Loxapine Capsules USP, 50mg, 100 count bottle, Rx only Manufactured By: Watson Laboratories Inc., Corona, CA 92880 NDC # 0591-0372-01
Why was Loxapine Capsules USP recalled?
Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #s: 104432A, 104433A, 121344A, 127024A, 144290A
- Product
- Loxapine Capsules USP, 50mg, 100 count bottle, Rx only Manufactured By: Watson Laboratories Inc., Corona, CA 92880 NDC # 0591-0372-01
- Recalling firm
- Watson Laboratories Inc
- Quantity
- 18,902 bottles
- Distribution
- Nationwide.
- Recall date
- July 11, 2012
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)